X0306 5 2020-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736937 Tarrabain Alex 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Financial Officer Common Stock 2020-01-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-02-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-03-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-04-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-05-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-06-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-07-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-08-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-09-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-10-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-11-16 4 J 0 L 3000 0 A 1457942 D Common Stock 2020-12-16 4 J 0 L 3000 0 A 1457942 D 36,000 shares of common stock of the issuer were issued as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 3,000 shares on the following dates: 1/16/2020, 2/16/2020, 3/16/2020, 4/16/2020, 5/16/2020, 6/16/2020, 7/16/2020, 8/16/2020, 9/16/2020, 10/16/2020, 11/16/2020 and 12/16/2020. Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000. Includes 21,371 shares held at brokerage. /s/ Alex Tarrabain 2021-04-29